Cargando…
A Combinatorial Investigation of the Response to Anti-angiogenic Therapy in Breast Cancer: New Strategies for Patient Selection and Opportunities for Reconsidering Anti-VEGF, Anti-PI3K and Checkpoint Inhibition
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006723/ https://www.ncbi.nlm.nih.gov/pubmed/27506898 http://dx.doi.org/10.1016/j.ebiom.2016.07.038 |
| _version_ | 1782451113933406208 |
|---|---|
| author | Labanca, Valentina Bertolini, Francesco |
| author_facet | Labanca, Valentina Bertolini, Francesco |
| author_sort | Labanca, Valentina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5006723 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50067232016-09-09 A Combinatorial Investigation of the Response to Anti-angiogenic Therapy in Breast Cancer: New Strategies for Patient Selection and Opportunities for Reconsidering Anti-VEGF, Anti-PI3K and Checkpoint Inhibition Labanca, Valentina Bertolini, Francesco EBioMedicine Commentary Elsevier 2016-08-02 /pmc/articles/PMC5006723/ /pubmed/27506898 http://dx.doi.org/10.1016/j.ebiom.2016.07.038 Text en © 2016 Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Commentary Labanca, Valentina Bertolini, Francesco A Combinatorial Investigation of the Response to Anti-angiogenic Therapy in Breast Cancer: New Strategies for Patient Selection and Opportunities for Reconsidering Anti-VEGF, Anti-PI3K and Checkpoint Inhibition |
| title | A Combinatorial Investigation of the Response to Anti-angiogenic Therapy in Breast Cancer: New Strategies for Patient Selection and Opportunities for Reconsidering Anti-VEGF, Anti-PI3K and Checkpoint Inhibition |
| title_full | A Combinatorial Investigation of the Response to Anti-angiogenic Therapy in Breast Cancer: New Strategies for Patient Selection and Opportunities for Reconsidering Anti-VEGF, Anti-PI3K and Checkpoint Inhibition |
| title_fullStr | A Combinatorial Investigation of the Response to Anti-angiogenic Therapy in Breast Cancer: New Strategies for Patient Selection and Opportunities for Reconsidering Anti-VEGF, Anti-PI3K and Checkpoint Inhibition |
| title_full_unstemmed | A Combinatorial Investigation of the Response to Anti-angiogenic Therapy in Breast Cancer: New Strategies for Patient Selection and Opportunities for Reconsidering Anti-VEGF, Anti-PI3K and Checkpoint Inhibition |
| title_short | A Combinatorial Investigation of the Response to Anti-angiogenic Therapy in Breast Cancer: New Strategies for Patient Selection and Opportunities for Reconsidering Anti-VEGF, Anti-PI3K and Checkpoint Inhibition |
| title_sort | combinatorial investigation of the response to anti-angiogenic therapy in breast cancer: new strategies for patient selection and opportunities for reconsidering anti-vegf, anti-pi3k and checkpoint inhibition |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006723/ https://www.ncbi.nlm.nih.gov/pubmed/27506898 http://dx.doi.org/10.1016/j.ebiom.2016.07.038 |
| work_keys_str_mv | AT labancavalentina acombinatorialinvestigationoftheresponsetoantiangiogenictherapyinbreastcancernewstrategiesforpatientselectionandopportunitiesforreconsideringantivegfantipi3kandcheckpointinhibition AT bertolinifrancesco acombinatorialinvestigationoftheresponsetoantiangiogenictherapyinbreastcancernewstrategiesforpatientselectionandopportunitiesforreconsideringantivegfantipi3kandcheckpointinhibition AT labancavalentina combinatorialinvestigationoftheresponsetoantiangiogenictherapyinbreastcancernewstrategiesforpatientselectionandopportunitiesforreconsideringantivegfantipi3kandcheckpointinhibition AT bertolinifrancesco combinatorialinvestigationoftheresponsetoantiangiogenictherapyinbreastcancernewstrategiesforpatientselectionandopportunitiesforreconsideringantivegfantipi3kandcheckpointinhibition |